Zoetis Shares Outstanding 2011-2018 | ZTS

Zoetis shares outstanding history from 2011 to 2018. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Zoetis shares outstanding for the quarter ending September 30, 2018 were 0.486B, a 1.34% decline year-over-year.
  • Zoetis 2017 shares outstanding were 0.493B, a 1.02% decline from 2016.
  • Zoetis 2016 shares outstanding were 0.498B, a 0.76% decline from 2015.
  • Zoetis 2015 shares outstanding were 0.502B, a 0% decline from 2014.
Zoetis Annual Shares Outstanding
(Millions of Shares)
2017 493
2016 498
2015 502
2014 502
2013 500
2012 500
2011 500
2010 500
Zoetis Quarterly Shares Outstanding
(Millions of Shares)
Q3 2018 486
Q2 2018 488
Q1 2018 490
Q4 2017 493
Q3 2017 492
Q2 2017 494
Q1 2017 495
Q4 2016 498
Q3 2016 498
Q2 2016 499
Q1 2016 500
Q4 2015 502
Q3 2015 502
Q2 2015 500
Q1 2015 503
Q4 2014 502
Q3 2014 502
Q2 2014 502
Q1 2014 501
Q4 2013 500
Q3 2013 500
Q2 2013 500
Q1 2013 500
Q4 2012 500
Q3 2012 500
Q2 2012 500
Q1 2012 500
Q4 2011 0
Q4 2010 0
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $44.331B $5.307B
Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products and genetic tests and supported by a range of services.
Stock Name Country Market Cap PE Ratio
Shire (SHPG) Ireland $53.371B 11.43
Grifols (GRFS) Spain $14.524B 17.73
Tilray (TLRY) United States $10.290B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $8.614B 12.36
Neurocrine Biosciences (NBIX) United States $8.160B 1799.60
Ionis Pharmaceuticals (IONS) United States $7.393B 0.00
Nektar Therapeutics (NKTR) United States $6.617B 9.49
Catalent (CTLT) United States $5.726B 24.02
Impax Laboratories (AMRX) United States $5.526B 0.00
Sage Therapeutics (SAGE) United States $5.355B 0.00
United Therapeutics (UTHR) United States $5.295B 8.66
Loxo Oncology (LOXO) United States $4.792B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.937B 14.58
FibroGen (FGEN) United States $3.437B 0.00
USANA Health Sciences (USNA) United States $2.884B 24.55
Endo (ENDP) Ireland $2.847B 4.36
Xencor (XNCR) United States $2.239B 0.00
Heron Therapeutics (HRTX) United States $2.084B 0.00
Madrigal Pharmaceuticals (MDGL) United States $2.000B 0.00
Aerie Pharmaceuticals (AERI) United States $1.949B 0.00
Endocyte (ECYT) United States $1.943B 0.00
TESARO (TSRO) United States $1.924B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.924B 260.00
Ironwood Pharmaceuticals (IRWD) United States $1.846B 0.00
PTC Therapeutics (PTCT) United States $1.711B 0.00
Zogenix (ZGNX) United States $1.710B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.573B 19.24
Corcept Therapeutics (CORT) United States $1.503B 22.07
Theravance Biopharma (TBPH) Cayman Islands $1.454B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.413B 0.00
Portola Pharmaceuticals (PTLA) United States $1.329B 0.00
Tricida (TCDA) United States $1.318B 0.00
Esperion Therapeutics (ESPR) United States $1.300B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.179B 0.00
TherapeuticsMD (TXMD) United States $1.158B 0.00
ImmunoGen (IMGN) United States $0.892B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.863B 0.00
Radius Health (RDUS) United States $0.761B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.690B 0.00
Karyopharm Therapeutics (KPTI) United States $0.678B 0.00
Flexion Therapeutics (FLXN) United States $0.638B 0.00
Collegium Pharmaceutical (COLL) United States $0.578B 0.00
GlycoMimetics (GLYC) United States $0.515B 0.00
ChemoCentryx (CCXI) United States $0.514B 40.68
Rigel Pharmaceuticals (RIGL) United States $0.477B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.468B 0.00
Akebia Therapeutics (AKBA) United States $0.455B 0.00
Siga Technologies (SIGA) United States $0.448B 0.00
Odonate Therapeutics (ODT) United States $0.443B 0.00
Xeris Pharmaceuticals (XERS) United States $0.439B 0.00
Dova Pharmaceuticals (DOVA) United States $0.437B 0.00
ArQule (ARQL) United States $0.436B 0.00
OptiNose (OPTN) United States $0.425B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.423B 24.96
Aquestive Therapeutics (AQST) United States $0.421B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.412B 0.00
Dermira (DERM) United States $0.409B 0.00
Forty Seven (FTSV) United States $0.404B 0.00
CASI Pharmaceuticals (CASI) United States $0.391B 0.00
Zafgen (ZFGN) United States $0.364B 0.00
Aclaris Therapeutics (ACRS) United States $0.361B 0.00
Depomed (ASRT) United States $0.351B 13.07
Corbus Pharmaceuticals Holdings (CRBP) United States $0.347B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.346B 0.00
Mast Therapeutics (SVRA) United States $0.330B 0.00
Tapimmune (MRKR) United States $0.329B 0.00
Minerva Neurosciences (NERV) United States $0.327B 0.00
KalVista Pharmaceuticals (KALV) United States $0.324B 0.00
Aratana Therapeutics (PETX) United States $0.319B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.317B 0.00
Concert Pharmaceuticals (CNCE) United States $0.313B 0.00
Translate Bio (TBIO) United States $0.307B 0.00
Majesco Entertainment (PTE) United States $0.269B 0.00
Affimed (AFMD) Germany $0.266B 0.00
IMV INC (IMV) Canada $0.254B 0.00
Opexa Therapeutics (ACER) United States $0.249B 0.00
Lannett Co Inc (LCI) United States $0.233B 2.03
Tyme Technologies (TYME) United States $0.232B 0.00
Aldeyra Therapeutics (ALDX) United States $0.231B 0.00
Ocular Therapeutix (OCUL) United States $0.219B 0.00
MEI Pharma (MEIP) United States $0.216B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.212B 0.00
Galectin Therapeutics (GALT) United States $0.208B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.205B 0.00
Calithera Biosciences (CALA) United States $0.197B 0.00
Neon Therapeutics (NTGN) United States $0.197B 0.00
ElectroCore (ECOR) United States $0.192B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.186B 0.00
Ardelyx (ARDX) United States $0.186B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.181B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.181B 0.00
Nature's Sunshine Products (NATR) United States $0.177B 0.00
Molecular Templates (MTEM) United States $0.173B 0.00
Redhill Biopharma (RDHL) Israel $0.168B 0.00
ContraFect (CFRX) United States $0.166B 0.00
MediWound (MDWD) Israel $0.162B 0.00
DURECT (DRRX) United States $0.144B 0.00
Jounce Therapeutics (JNCE) United States $0.144B 0.00
Recro Pharma (REPH) United States $0.141B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.140B 0.00
Melinta Therapeutics (MLNT) United States $0.139B 0.00
Champions Oncology (CSBR) United States $0.139B 0.00
Adherex Technologies (FENC) United States $0.137B 0.00
ProNAi Therapeutics (SRRA) Canada $0.127B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.123B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.122B 0.00
Cardiome Pharma (CORV) Canada $0.113B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.099B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.099B 0.00
CTI BioPharma (CTIC) United States $0.098B 0.00
Synergy Pharmaceuticals (SGYP) United States $0.097B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.082B 0.00
Iterum Therapeutics (ITRM) Ireland $0.081B 0.00
Infinity Pharmaceuticals (INFI) United States $0.080B 0.00
Otonomy (OTIC) United States $0.076B 0.00
Achaogen (AKAO) United States $0.076B 0.00
Nivalis Therapeutics (ALPN) United States $0.073B 0.00
BioLineRx (BLRX) Israel $0.071B 0.00
Natural Alternatives (NAII) United States $0.070B 6.85
KemPharm (KMPH) United States $0.067B 0.00
Immune Design (IMDZ) United States $0.066B 0.00
Novan (NOVN) United States $0.063B 0.00
Forward Pharma (FWP) Denmark $0.060B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.059B 0.00
Avenue Therapeutics (ATXI) United States $0.059B 0.00
Neos Therapeutics (NEOS) United States $0.058B 0.00
Genocea Biosciences (GNCA) United States $0.050B 0.00
Capnia (SLNO) United States $0.045B 0.00
Mannatechorporated (MTEX) United States $0.043B 0.00
Trillium Therapeutics (TRIL) Canada $0.043B 0.00
Heat Biologics (HTBX) United States $0.041B 0.00
SCYNEXIS (SCYX) United States $0.039B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.038B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.036B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.036B 0.00
ProPhase Labs (PRPH) United States $0.035B 0.00
Lipocine (LPCN) United States $0.031B 0.00
Biomerica (BMRA) United States $0.027B 0.00
Onconova Therapeutics (ONTX) United States $0.025B 0.00
Xenetic Biosciences (XBIO) United States $0.024B 0.00
HANCOCK JAFFE (HJLI) United States $0.023B 0.00
Jaguar Animal Health (JAGX) United States $0.022B 0.00
Citius Pharmaceuticals (CTXR) United States $0.021B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.021B 0.00
Cyanotech (CYAN) United States $0.021B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.019B 0.00
Aviragen Therapeutics (VXRT) United States $0.019B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.019B 6.75
ESSA Pharma (EPIX) Canada $0.019B 0.00
Pain Therapeutics (PTIE) United States $0.019B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.018B 0.00
Shineco (TYHT) China $0.016B 1.60
Aradigm (ARDM) United States $0.015B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.014B 0.00
Regulus Therapeutics (RGLS) United States $0.013B 0.00
OncoGenex Pharmaceuticals (ACHV) United States $0.012B 0.00
Skyline Medical (AIPT) United States $0.012B 0.00
Midatech Pharma (MTP) United Kingdom $0.011B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.010B 0.00
Apricus Biosciences (APRI) United States $0.008B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.007B 0.00
Bio-Path Holdings (BPTH) United States $0.006B 0.00
PharmAthene (ALT) United States $0.006B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.004B 0.00
Bio Blast Pharma (ORPN) Israel $0.004B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.003B 0.00
Intellipharmaceutics (IPCI) Canada $0.002B 0.00
RXi Pharmaceuticals (RXII) United States $0.001B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00